Antenatal Steroid Exposure Among Term Newborns

Taylor S Freret; Kaitlyn E James; Alexander Melamed; Cynthia Gyamfi-Bannerman; Anjali J Kaimal; Mark A Clapp

doi:10.1001/jamapediatrics.2022.3251

Antenatal Steroid Exposure Among Term Newborns

JAMA Pediatr. 2022 Dec 1;176(12):1260-1261. doi: 10.1001/jamapediatrics.2022.3251.

Authors

Taylor S Freret¹, Kaitlyn E James¹, Alexander Melamed², Cynthia Gyamfi-Bannerman³, Anjali J Kaimal¹, Mark A Clapp¹

Affiliations

¹ Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston.
² Department of Obstetrics and Gynecology, Columbia University, New York, New York.
³ Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla.

No abstract available

Plain language summary

This cross-sectional study evaluates the association between dissemination of the Antenatal Late Preterm Steroid trial and changes in steroid exposure among term newborns.

MeSH terms

Betamethasone*
Female
Gestational Age
Humans
Infant, Newborn
Pregnancy
Premature Birth*

Substances

Betamethasone